Matches in Wikidata for { <http://www.wikidata.org/entity/Q92374063> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q92374063 description "article scientifique publié en 2020" @default.
- Q92374063 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92374063 description "scientific article published on 02 January 2020" @default.
- Q92374063 description "wetenschappelijk artikel" @default.
- Q92374063 description "наукова стаття, опублікована 2 січня 2020" @default.
- Q92374063 name "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 name "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 type Item @default.
- Q92374063 label "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 label "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 prefLabel "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 prefLabel "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 P1433 Q92374063-7BFE145D-25D8-4986-A804-18FA8B5FCAF6 @default.
- Q92374063 P1476 Q92374063-E839FDB0-3AE8-4B03-9968-13CD592E7A67 @default.
- Q92374063 P2093 Q92374063-3963B190-FC8B-410C-BE10-5EE92F90470E @default.
- Q92374063 P2093 Q92374063-3D4C2F08-5293-47D7-9F18-9AF1492A773A @default.
- Q92374063 P2093 Q92374063-55C2232A-3941-4948-A7DF-E83242A50420 @default.
- Q92374063 P2093 Q92374063-7842F02B-900A-40AB-9D0E-49C06E1A06D9 @default.
- Q92374063 P2093 Q92374063-81EA8FD5-86E4-42FE-BA53-6030A69B510A @default.
- Q92374063 P2093 Q92374063-B1C54AED-1695-4862-BB00-75491E1E67F5 @default.
- Q92374063 P2093 Q92374063-CCD2AA48-9561-4073-9CF0-6E1BBBE0108A @default.
- Q92374063 P304 Q92374063-FF6D10DF-09BC-4CD8-A041-D643BAE1BB35 @default.
- Q92374063 P31 Q92374063-96929F0A-5FCC-4892-A9A1-B16354AA9FD6 @default.
- Q92374063 P356 Q92374063-6A4F0302-98B0-40E2-8A4F-90D7BC0E4F07 @default.
- Q92374063 P433 Q92374063-C6C3B47B-8EC1-4C8A-B714-A5F8385F0B78 @default.
- Q92374063 P478 Q92374063-FE9904D4-665E-46EA-9454-DE0927A9F9AD @default.
- Q92374063 P577 Q92374063-67B95700-7987-435D-9B54-CA1B8A619131 @default.
- Q92374063 P698 Q92374063-A367D4E8-353D-4784-B147-85D753045E46 @default.
- Q92374063 P356 JCO.19.02509 @default.
- Q92374063 P698 31895605 @default.
- Q92374063 P1433 Q400292 @default.
- Q92374063 P1476 "Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?" @default.
- Q92374063 P2093 "Daisuke Kiuchi" @default.
- Q92374063 P2093 "Emi Kubo" @default.
- Q92374063 P2093 "Eriko Satomi" @default.
- Q92374063 P2093 "Hiroto Ishiki" @default.
- Q92374063 P2093 "Masaki Shimizu" @default.
- Q92374063 P2093 "Sayuri Yokota" @default.
- Q92374063 P2093 "Tomohiro Tanaka" @default.
- Q92374063 P304 "843-844" @default.
- Q92374063 P31 Q13442814 @default.
- Q92374063 P356 "10.1200/JCO.19.02509" @default.
- Q92374063 P433 "8" @default.
- Q92374063 P478 "38" @default.
- Q92374063 P577 "2020-01-02T00:00:00Z" @default.
- Q92374063 P698 "31895605" @default.